1
|
Ikenohuchi YJ, Silva MDS, Rego CMA, Francisco AF, da Silva Setúbal S, Ferreira E Ferreira AA, Boeno CN, Santana HM, Felipin KP, de Lima AM, de Mattos Fontes MR, Paloschi MV, Soares AM, Zuliani JP. A C-type lectin induces NLRP3 inflammasome activation via TLR4 interaction in human peripheral blood mononuclear cells. Cell Mol Life Sci 2023; 80:188. [PMID: 37349530 PMCID: PMC11073222 DOI: 10.1007/s00018-023-04839-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 05/17/2023] [Accepted: 06/14/2023] [Indexed: 06/24/2023]
Abstract
Lectins are a large group of proteins found in many snake venoms. BjcuL is a C-type lectin from Bothrops jararacussu snake venom that does not present cytotoxicity action on human peripheral blood mononuclear cells (PBMCs) at concentrations of 5 and 10 μg/mL. BjcuL demonstrates an immunomodulatory role in PBMCs with the production of pro- and anti-inflammatory cytokines (IL-2, IL-10, IFN-γ, IL-6, TNF-α, and IL-17) in addition to stimulate T cells to produce reactive oxygen species (ROS) that could play a role in the acute inflammatory reaction observed in the victims. Inflammasomes are an essential arm in cells of innate immunity to detect and sense a range of endogenous or exogenous, sterile, or infectious stimuli to elicit cellular responses and effector mechanisms. NLRP3 inflammasome is a significant target for this study, because the lectin is responsible for leukocyte activation stimulating the release of inflammatory mediators, which results in dynamic cellular responses to remove the detrimental process to the body in snakebites. Thus, this study aimed to investigate how isolated BjcuL from B. jararacussu venom affects NLRP3 inflammasome activation on PBMCs. For this, the cells were isolated by density gradient and incubated with BjcuL at different periods and concentrations for the evaluation of the activation of the NLRP3 inflammasome through gene and protein expressions of ASC, CASPASE-1, and NLRP3 by RT-qPCR, Western blot, and immunofluorescence, as well as the participation of Toll-like receptor 4 (TLR4) and ROS in the IL-1β production, a product resultant of the NLRP3 inflammasome activation. Herein, BjcuL interacts with TLR4 as demonstrated by in vitro and in silico studies and induces cytokines release via NF-κB signaling. By genic and protein expression assays, BjcuL activates NLRP3 inflammasome, and the pharmacological modulation with LPS-RS, an antagonist of TLR4; LPS-SM, an agonist of TLR4; MCC950, a specific NLRP3 inhibitor, and rotenone, an inhibitor of mitochondrial ROS, confirmed the participation of TLR4 and ROS in the NLRP3 inflammasome activation and IL-1β liberation. The effects of BjcuL on the regulation and activation of the NLRP3 inflammasome complex via TLR4 activation with ROS participation may be determinant for the development of the inflammatory local effects seen in snakebite victims. In addition, in silico together with in vitro studies provide information that may be useful in the rational design of TLR agonists as well as new adjuvants for immunomodulatory therapy.
Collapse
Affiliation(s)
- Yoda Janaina Ikenohuchi
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Milena Daniela Souza Silva
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Cristina Matiele Alves Rego
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Aleff Ferreira Francisco
- Department of Physics and Biophysics and Pharmacology, Institute of Biosciences, São Paulo State University, UNESP, Botucatu, SP, Brazil
- Laboratory of Biotechnology of Proteins and Bioactive Compounds Applied to Health (LABIOPROT) and National Institute of Science and Technology in Epidemiology of the Occidental Amazonia (INCT-EPIAMO), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Sulamita da Silva Setúbal
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Alex Augusto Ferreira E Ferreira
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Charles Nunes Boeno
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Hallison Mota Santana
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Kátia Paula Felipin
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Anderson Maciel de Lima
- Laboratory of Biotechnology of Proteins and Bioactive Compounds Applied to Health (LABIOPROT) and National Institute of Science and Technology in Epidemiology of the Occidental Amazonia (INCT-EPIAMO), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Marcos Roberto de Mattos Fontes
- Department of Physics and Biophysics and Pharmacology, Institute of Biosciences, São Paulo State University, UNESP, Botucatu, SP, Brazil
- Institute for Advance Studies of the Sea (IEAMAR), São Paulo State University, UNESP, São Vicente, SP, Brazil
| | - Mauro Valentino Paloschi
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil
| | - Andreimar Martins Soares
- Laboratory of Biotechnology of Proteins and Bioactive Compounds Applied to Health (LABIOPROT) and National Institute of Science and Technology in Epidemiology of the Occidental Amazonia (INCT-EPIAMO), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Juliana Pavan Zuliani
- Laboratory of Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR364, Km 3.5, Porto Velho, RO, CEP 76812-245, Brazil.
- Department of Medicine, Federal University of Rondônia, UNIR, Porto Velho, RO, Brazil.
| |
Collapse
|
3
|
Sartim MA, Sampaio SV. Snake venom galactoside-binding lectins: a structural and functional overview. J Venom Anim Toxins Incl Trop Dis 2015; 21:35. [PMID: 26413085 PMCID: PMC4583214 DOI: 10.1186/s40409-015-0038-3] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2014] [Accepted: 09/16/2015] [Indexed: 12/13/2022] Open
Abstract
Snake venom galactoside-binding lectins (SVgalLs) comprise a class of toxins capable of recognizing and interacting with terminal galactoside residues of glycans. In the past 35 years, since the first report on the purification of thrombolectin from Bothrops atrox snake venom, several SVgalLs from Viperidae and Elapidae snake families have been described, as has progressive improvement in the investigation of structural/functional aspects of these lectins. Moreover, the advances of techniques applied in protein-carbohydrate recognition have provided important approaches in order to screen for possible biological targets. The present review describes the efforts over the past 35 years to elucidate SVgalLs, highlighting their structure and carbohydrate recognition function involved in envenomation pathophysiology and potential biomedical applications.
Collapse
Affiliation(s)
- Marco A. Sartim
- Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Avenida do Café, s/n, Ribeirão Preto, SP CEP 14040-903 Brazil
| | - Suely V. Sampaio
- Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (USP), Avenida do Café, s/n, Ribeirão Preto, SP CEP 14040-903 Brazil
| |
Collapse
|
4
|
Antitumoral potential of Tunisian snake venoms secreted phospholipases A2. BIOMED RESEARCH INTERNATIONAL 2013; 2013:391389. [PMID: 23509718 PMCID: PMC3581298 DOI: 10.1155/2013/391389] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/19/2012] [Accepted: 09/04/2012] [Indexed: 11/17/2022]
Abstract
Phospholipases type A2 (PLA2s) are the most abundant proteins found in Viperidae snake venom. They are quite fascinating from both a biological and structural point of view. Despite similarity in their structures and common catalytic properties, they exhibit a wide spectrum of pharmacological activities. Besides being hydrolases, secreted phospholipases A2 (sPLA2) are an important group of toxins, whose action at the molecular level is still a matter of debate. These proteins can display toxic effects by different mechanisms. In addition to neurotoxicity, myotoxicity, hemolytic activity, antibacterial, anticoagulant, and antiplatelet effects, some venom PLA2s show antitumor and antiangiogenic activities by mechanisms independent of their enzymatic activity. This paper aims to discuss original finding against anti-tumor and anti-angiogenic activities of sPLA2 isolated from Tunisian vipers: Cerastes cerastes and Macrovipera lebetina, representing new tools to target specific integrins, mainly, α5β1 and αv integrins.
Collapse
|